Is Healthy Life overvalued or undervalued?

As of 8 October 2025, Healthy Life's valuation grade has moved from attractive to very attractive, indicating a significant positive shift in its perceived value. The company is currently assessed as undervalued, particularly when compared to its peers in the FMCG sector. Key ratios include a PE Ratio of 24.69, an EV to EBITDA of 16.40, and a ROCE of 13.87%.
In comparison, Hindustan Unilever and Nestle India, both categorized as very expensive, have PE Ratios of 55.27 and 75.42, respectively, highlighting the relative attractiveness of Healthy Life's valuation. Despite recent stock performance showing a decline of 68.77% year-to-date against a 4.65% rise in the Sensex, the company's strong fundamentals suggest it may present a compelling investment opportunity moving forward.